Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vanda

Investors look beyond the 'Magnificent 7' as Wall Street embraces the 'FAB 10'

SpaceX's record-breaking market debut has pushed Wall Street to widen its favourite shorthand of the so-called 'Magnificent 7', with strategists folding Elon Musk's firm, OpenAI and Anthropic into a new 'FAB 10' label that captures the next phase of the AI trade.

Vanda Research Says Retail Investors are Buying the Tesla Stock Dip. Should you?

Vanda Research Says Retail Investors are Buying the Tesla Stock Dip. Should you?

Tesla stock is down in 2026 and retail investors are piling in. But with missed delivery targets and a JPMorgan "Sell" rating, is buying the dip actually smart?

From dabblers to day traders, small investors' impact on Wall Street grows even in volatile market

From dabblers to day traders, small investors' impact on Wall Street grows even in volatile market

For years, retail investors were dismissed by some on Wall Street as “dumb money.”

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Novo Nordisk A/S (NYSE:NVO) Wegovy.

Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Wegovy.

AnaptysBio Charts Path To Split Into Two Public Companies By 2026

AnaptysBio, Inc. (NASDAQ:ANAB) announced on Tuesday that it plans to explore separating its business into two independent, publicly traded companies.

3 Biotech Stocks to Watch for Lucrative Gains

The biotech sector’s robust long-term growth is driven by strong government support, the rising foothold of personalized medicine, the growing number of orphan drug formulations, and rapid AI adoption. Hence, biotech stocks G1 Therapeutics (GTHX), Vanda Pharmaceuticals (VNDA), and Royalty Pharma (RPRX) could be ideal additions to your watchlist. Keep…

inkl

Read news from The Economist, FT, and more,
with one subscription

Jumpstart Your Portfolio With These 3 Biotech Stocks

Jumpstart Your Portfolio With These 3 Biotech Stocks

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….

Tesla Stock More Popular Than Ever With Individuals

Tesla Stock More Popular Than Ever With Individuals

With retail investors spending tens of billions spent on Tesla shares already purchased this year, the company outpaces any other security by far.

Why Are Vanda Pharma Shares Plunging Today?

Why Are Vanda Pharma Shares Plunging Today?

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of gastroparesis.

1

People

206,612 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

the Wall Street Journal

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

405,269 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play